Frank Oellien
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Frank Oellien has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Udo E. W. Lange
Neuroscience Discovery, Medicinal Chemistry, AbbVie Deutschland GmbH & Co KG, Knollstrasse, 67061 Ludwigshafen, Germany
3 shared publications - Clare Vickers
Neuroscience Discovery, Medicinal Chemistry AbbVie (Deutschland) GmbH & Co. KG Knollstrasse D-67061 Ludwigshafen Germany
2 shared publications - Gisela Backfisch
Abbott GmbH & Co. KG, D-67008 Ludwigshafen, Germany
2 shared publications - Isabel Piel
Bayer AG Wuppertal Germany
2 shared publications - Carmen Esposito
Laboratory of Physical Chemistry, ETH Zürich, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland
1 shared publication - Sereina Riniker
Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 2, Zürich, Switzerland, 8093
1 shared publication
Latest Publications
- 7 August 2020
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 60 (10) , 4730-4749
Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein Substrates
The efflux transporter P-glycoprotein (P-gp) is responsible for the extrusion of a wide variety of molecules, including drug molecules, from the cell. P-gp mediated efflux transport limits therefore the bioavailability of drugs. To identify potential P-gp substrates early in the drug discovery process, in silico models have been developed based on structural and physicochemical descriptors. In this study, we investigate the use of molecular dynamics fingerprints (MDFPs) as an orthogonal descriptor for the training of machine learning (ML) models to classify small molecules into substrates and nonsubstrates of P-gp. MDFPs encode the information from short MD simulations of the molecules in different environments (water, membrane, or protein pocket). The performance of the MDFPs is compared to that of commonly used 2D molecular descriptors, including structure-based and property-based descriptors, on both an in-house dataset (3930 compounds) and a public dataset from ChEMBL (1114 compounds). We find that all tested classifiers interpolate well, achieving high accuracy on chemically diverse subsets. However, by challenging the models with external validation and prospective analysis, we show that only tree-based ML models trained on MDFPs or property-based descriptors generalize well to regions of the chemical space not covered by the training set.
- 7 August 2020
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 60 (10) , 4730-4749
Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein Substrates
The efflux transporter P-glycoprotein (P-gp) is responsible for the extrusion of a wide variety of molecules, including drug molecules, from the cell. P-gp mediated efflux transport limits therefore the bioavailability of drugs. To identify potential P-gp substrates early in the drug discovery process, in silico models have been developed based on structural and physicochemical descriptors. In this study, we investigate the use of molecular dynamics fingerprints (MDFPs) as an orthogonal descriptor for the training of machine learning (ML) models to classify small molecules into substrates and nonsubstrates of P-gp. MDFPs encode the information from short MD simulations of the molecules in different environments (water, membrane, or protein pocket). The performance of the MDFPs is compared to that of commonly used 2D molecular descriptors, including structure-based and property-based descriptors, on both an in-house dataset (3930 compounds) and a public dataset from ChEMBL (1114 compounds). We find that all tested classifiers interpolate well, achieving high accuracy on chemically diverse subsets. However, by challenging the models with external validation and prospective analysis, we show that only tree-based ML models trained on MDFPs or property-based descriptors generalize well to regions of the chemical space not covered by the training set.
- Open Access
- 5 December 2018
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (68)
Frontispiece: Enzymatic Late‐Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groups
- 5 December 2018
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (68)
Open AccessFrontispiece: Enzymatic Late‐Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groups
- 19 November 2018
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (68) , 17936-17947
Enzymatic Late‐Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groups
Late‐stage functionalization of lead compounds is of high interest in drug discovery since it offers an easy access to metabolites and derivatives of a lead compound without the need to redesign an often long multistep synthesis. Owing to their high degree of chemoselectivity, biocatalytic transformations, enzymatic oxidations in particular, are potentially very powerful because they could allow the synthesis of less lipophilic derivatives of a lead compound. In the majority of cases, enzymatic oxidations have been used in an empirical way as their regioselectivity is difficult to predict. In this publication, the concept of using docking/protecting groups in a biomimetic fashion was investigated, which could help steer the regioselectivity of a P450BM3‐mediated oxidation. A novel set of docking/protecting groups was designed that can be cleaved under very mild conditions and address the often problematic aqueous solubility of the substrates. Vabicaserin was used as tool compound containing typical groups such as basic, aliphatic, and aromatic moieties. The results were rationalized with the help of in silico docking and molecular dynamic studies.
- 19 November 2018
- Published by Wiley in Chemistry – A European Journal
- Vol. 24 (68) , 17936-17947
Enzymatic Late‐Stage Oxidation of Lead Compounds with Solubilizing Biomimetic Docking/Protecting groups
Late‐stage functionalization of lead compounds is of high interest in drug discovery since it offers an easy access to metabolites and derivatives of a lead compound without the need to redesign an often long multistep synthesis. Owing to their high degree of chemoselectivity, biocatalytic transformations, enzymatic oxidations in particular, are potentially very powerful because they could allow the synthesis of less lipophilic derivatives of a lead compound. In the majority of cases, enzymatic oxidations have been used in an empirical way as their regioselectivity is difficult to predict. In this publication, the concept of using docking/protecting groups in a biomimetic fashion was investigated, which could help steer the regioselectivity of a P450BM3‐mediated oxidation. A novel set of docking/protecting groups was designed that can be cleaved under very mild conditions and address the often problematic aqueous solubility of the substrates. Vabicaserin was used as tool compound containing typical groups such as basic, aliphatic, and aromatic moieties. The results were rationalized with the help of in silico docking and molecular dynamic studies.